Halbgebauer, S., Oeckl, P., Steinacker, P., Yilmazer-Hanke, D., Straub, S., Arnim, C. v., . . . Otto, M. (2021). Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease. Journal of neurology, neurosurgery, and psychiatry, 92(4), . https://doi.org/10.1136/jnnp-2020-324306
Chicago-Zitierstil (17. Ausg.)Halbgebauer, Steffen, et al. "Beta-synuclein in Cerebrospinal Fluid as an Early Diagnostic Marker of Alzheimer’s Disease." Journal of Neurology, Neurosurgery, and Psychiatry 92, no. 4 (2021). https://doi.org/10.1136/jnnp-2020-324306.
MLA-Zitierstil (9. Ausg.)Halbgebauer, Steffen, et al. "Beta-synuclein in Cerebrospinal Fluid as an Early Diagnostic Marker of Alzheimer’s Disease." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 92, no. 4, 2021, https://doi.org/10.1136/jnnp-2020-324306.